Nucleic acid binding, RNA-binding
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | yes | yes: 12 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 21 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pescher et al. (upgregulation) | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Lahav et al. - mRNA
- Protein
|
Related structures:
AlphaFold database: A0A3Q8IF50
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0003729 | mRNA binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.265 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.455 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.592 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.265 |
CLV_PCSK_PC7_1 | 98 | 104 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.306 |
DOC_CKS1_1 | 38 | 43 | PF01111 | 0.478 |
DOC_CYCLIN_RxL_1 | 192 | 200 | PF00134 | 0.451 |
DOC_MAPK_gen_1 | 230 | 239 | PF00069 | 0.460 |
DOC_MAPK_gen_1 | 24 | 32 | PF00069 | 0.556 |
DOC_MAPK_MEF2A_6 | 233 | 241 | PF00069 | 0.464 |
DOC_PP4_FxxP_1 | 38 | 41 | PF00568 | 0.467 |
DOC_USP7_MATH_1 | 141 | 145 | PF00917 | 0.742 |
DOC_USP7_MATH_1 | 170 | 174 | PF00917 | 0.645 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.463 |
DOC_WW_Pin1_4 | 37 | 42 | PF00397 | 0.478 |
LIG_14-3-3_CanoR_1 | 129 | 138 | PF00244 | 0.748 |
LIG_APCC_ABBA_1 | 86 | 91 | PF00400 | 0.467 |
LIG_CtBP_PxDLS_1 | 257 | 263 | PF00389 | 0.467 |
LIG_FHA_1 | 177 | 183 | PF00498 | 0.719 |
LIG_FHA_1 | 56 | 62 | PF00498 | 0.467 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.489 |
LIG_LIR_Gen_1 | 213 | 221 | PF02991 | 0.467 |
LIG_LIR_Gen_1 | 40 | 49 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 213 | 218 | PF02991 | 0.467 |
LIG_LIR_Nem_3 | 254 | 258 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 40 | 45 | PF02991 | 0.478 |
LIG_Pex14_2 | 38 | 42 | PF04695 | 0.467 |
LIG_PTB_Apo_2 | 198 | 205 | PF02174 | 0.467 |
LIG_PTB_Apo_2 | 32 | 39 | PF02174 | 0.467 |
LIG_SH2_STAP1 | 57 | 61 | PF00017 | 0.467 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.705 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.430 |
LIG_SH3_3 | 105 | 111 | PF00018 | 0.555 |
LIG_SH3_4 | 184 | 191 | PF00018 | 0.615 |
LIG_SH3_CIN85_PxpxPR_1 | 181 | 186 | PF14604 | 0.742 |
LIG_TYR_ITIM | 55 | 60 | PF00017 | 0.319 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.615 |
MOD_CK2_1 | 241 | 247 | PF00069 | 0.320 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.681 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.319 |
MOD_Cter_Amidation | 193 | 196 | PF01082 | 0.471 |
MOD_Cter_Amidation | 95 | 98 | PF01082 | 0.319 |
MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.646 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.592 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.337 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.341 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.669 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.312 |
MOD_N-GLC_1 | 176 | 181 | PF02516 | 0.746 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.335 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.712 |
MOD_NEK2_1 | 197 | 202 | PF00069 | 0.334 |
MOD_NEK2_1 | 204 | 209 | PF00069 | 0.319 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.319 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.638 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.319 |
MOD_PKA_2 | 4 | 10 | PF00069 | 0.728 |
MOD_PKA_2 | 55 | 61 | PF00069 | 0.319 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.563 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.376 |
MOD_ProDKin_1 | 37 | 43 | PF00069 | 0.335 |
MOD_SUMO_for_1 | 242 | 245 | PF00179 | 0.376 |
TRG_DiLeu_BaEn_1 | 95 | 100 | PF01217 | 0.319 |
TRG_DiLeu_LyEn_5 | 95 | 100 | PF01217 | 0.319 |
TRG_ENDOCYTIC_2 | 57 | 60 | PF00928 | 0.319 |
TRG_ER_diArg_1 | 101 | 103 | PF00400 | 0.442 |
TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.679 |
TRG_ER_diArg_1 | 97 | 99 | PF00400 | 0.306 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I120 | Leptomonas seymouri | 83% | 100% |
A0A0R4IEW8 | Danio rerio | 26% | 67% |
A0A0S4JGF6 | Bodo saltans | 54% | 88% |
A0A1X0P606 | Trypanosomatidae | 67% | 98% |
A0A422MNR3 | Trypanosoma rangeli | 68% | 98% |
A4HMP2 | Leishmania braziliensis | 93% | 100% |
A4QNI8 | Xenopus tropicalis | 25% | 68% |
B5DF91 | Rattus norvegicus | 21% | 84% |
C9ZZE8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 60% | 91% |
E9AF44 | Leishmania major | 100% | 100% |
E9AHW1 | Leishmania infantum | 100% | 100% |
E9B699 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
P49314 | Nicotiana plumbaginifolia | 28% | 94% |
P70372 | Mus musculus | 21% | 84% |
Q08937 | Nicotiana sylvestris | 28% | 94% |
Q12926 | Homo sapiens | 25% | 76% |
Q14576 | Homo sapiens | 23% | 75% |
Q5R9Z6 | Pongo abelii | 25% | 76% |
Q60899 | Mus musculus | 24% | 76% |
Q60900 | Mus musculus | 23% | 75% |
Q7SZT7 | Xenopus laevis | 25% | 68% |
Q8CH84 | Rattus norvegicus | 25% | 76% |
Q91903 | Xenopus laevis | 23% | 70% |
V5BNY3 | Trypanosoma cruzi | 67% | 99% |